TCRR
State Street’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-137,219
| Closed | -$206K | – | 4789 |
|
|
2023
Q1 | $206K | Buy |
137,219
+27,900
| +26% | +$41.9K | ﹤0.01% | 4069 |
|
|
2022
Q4 | $109K | Hold |
109,319
| – | – | ﹤0.01% | 4347 |
|
|
2022
Q3 | $197K | Hold |
109,319
| – | – | ﹤0.01% | 4149 |
|
|
2022
Q2 | $317K | Sell |
109,319
-413,838
| -79% | -$1.2M | ﹤0.01% | 4008 |
|
|
2022
Q1 | $1.44M | Buy |
523,157
+7,968
| +2% | +$22K | ﹤0.01% | 3683 |
|
|
2021
Q4 | $2.4M | Sell |
515,189
-999,528
| -66% | -$4.66M | ﹤0.01% | 3583 |
|
|
2021
Q3 | $12.9M | Sell |
1,514,717
-716,507
| -32% | -$6.1M | ﹤0.01% | 2735 |
|
|
2021
Q2 | $36.6M | Buy |
2,231,224
+42,870
| +2% | +$703K | ﹤0.01% | 2078 |
|
|
2021
Q1 | $48.3M | Buy |
2,188,354
+1,211,294
| +124% | +$26.7M | ﹤0.01% | 1772 |
|
|
2020
Q4 | $30.2M | Buy |
977,060
+619,597
| +173% | +$19.2M | ﹤0.01% | 1973 |
|
|
2020
Q3 | $7.26M | Buy |
357,463
+98,780
| +38% | +$2.01M | ﹤0.01% | 2611 |
|
|
2020
Q2 | $3.97M | Buy |
258,683
+55,528
| +27% | +$853K | ﹤0.01% | 2873 |
|
|
2020
Q1 | $1.57M | Sell |
203,155
-197
| -0.1% | -$1.52K | ﹤0.01% | 3154 |
|
|
2019
Q4 | $2.9M | Buy |
203,352
+36,718
| +22% | +$524K | ﹤0.01% | 3104 |
|
|
2019
Q3 | $2.51M | Buy |
166,634
+151,934
| +1,034% | +$2.28M | ﹤0.01% | 3139 |
|
|
2019
Q2 | $152K | Buy |
+14,700
| New | +$152K | ﹤0.01% | 3630 |
|